Large keratoacanthomas treated with intralesional interferon alfa-2a
- 31 August 1993
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 29 (2) , 237-241
- https://doi.org/10.1016/0190-9622(93)70174-r
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intralesional interferon alfa-2b in the treatment of basal cell carcinoma: Immunohistochemical study on cellular immune reaction leading to tumor regressionJournal of the American Academy of Dermatology, 1991
- Multiple keratoacanthomas: a case report with evidence of regression with thymic hormoneBritish Journal of Dermatology, 1991
- TREATMENT OF LARGE BASAL-CELL CARCINOMAS WITH INTRALESIONAL INTERFERON-ALPHA-2aThe Lancet, 1988
- Intralesional interferon-alpha therapy in advanced malignant melanomaCancer, 1988
- Recombinant Interferon Alfa-2b in Plaque-Phase Mycosis FungoidesArchives of Dermatology, 1987
- The role of etretinate (Tegison; Tigason) in the management of keratoacanthomaJournal of the American Academy of Dermatology, 1985
- Treatment of keratoacanthoma with intralesional bleomycinBritish Journal of Dermatology, 1983
- Radiation therapy of keratoacanthomaInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Treatment of Keratoacanthomas with CurettageDermatology, 1977
- Keratoacanthoma Treated with MethotrexateArchives of Dermatology, 1973